Dr. Gholami is a board-certified surgeon scientist with dual fellowship training in Complex General Surgical Oncology and Hepatopancreatobiliary Surgery. She has focused her efforts on building a multi-disciplinary liver surgery program with liver-directed therapies/regional therapies, including a hepatic artery infusion pump program in patients with hepatobiliary and metastatic malignancies.

As a translational clinical researcher, Dr.Gholami’s research explores hepatobiliary tumor genetics, immune profiling, mechanism of immunologic resistance, and tumor microenvironment with current studies utilizing an ex-vivo 3D tumor on a chip model to evaluate and test novel therapies in patients with colorectal cancer.

Dr. Gholami has assumed various leadership roles including multiple societies (AHPBA, SSO, ASCO) and is currently the co-Chair of SWOG’s colon cancer sub-committee and serves on the NCI Colon Cancer Task Force. Dr. Gholami has a vested interest in developing novel diagnostic and prognostic biomarkers through designing high impact clinical trials to improve patient outcomes in colorectal cancer with liver metastases.